Assessment of Depression and Anxiety in Breast Cancer Patients Undergoing Radiotherapy in Palestine
The aim of this study was to assess experienced depression and anxiety among early breast cancer patients during radiotherapy. Women who started radiotherapy for breast cancer (n = 125) were asked to answer two questionnaires: The Hospital Anxiety and Depression Scale (HADS) and Radiotherapy Categorical Anxiety Scale during radiation therapy. The highest mean for anxiety and depression was for those who received education more than BA (SD = 3.2) and those who received less than secondary education (SD = 3.16), respectively. Also, the highest mean for patients’ number of children related with anxiety was for those who have more than three children (SD = 2.87), while for depression was (SD = 3.01). Anxiety and depression were also correlated to patient age where both showed the highest mean for those who aged between 31 and 40 (SD = 2.89), and those who are more than 51 years old (SD = 3.15), respectively. The highest anxiety and depression mean for treatment duration was for those treated for more than 3 months (SD = 3.2), and for those treated between 1 and 3 months (SD = 3), respectively. Some intervention may be needed to decrease the temporary anxiety and depression raised during radiotherapy for early-stage breast cancer patients.